PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
PHAS
Delisted
PHAS was delisted on the 2nd of November, 2022.
52 hedge funds and large institutions have $245M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 15 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
52
Holders Change
+33
Holders Change %
+173.68%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
36
Increased
15
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–